Emergent BioSolutions Q1 2026 Earnings EPS Surprise of 183 as the Company Returns to Profitability LUNR Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent NEE Q1 2026 Earnings Strong EPS Beat Despite Mixed Market Reaction THRY Q1 2026 Earnings Massive EPS Beat Lifts Shares as Expense Discipline Shines Traws Pharma Inc TRAW Q1 2026 Earnings BetterthanExpected Losses Highlight Cost Discipline Amid PreRevenue Phase AMPH Q1 2026 Earnings EPS Misses Estimates as Amphastar Faces Operational Pressures